SCHEMBL10072719

SCHEMBL10072719

Cc1ccc(-c2ccc3c(c2)C(C)(C)c2cc(-c4ccc(-c5c6ccccc6c(-c6ccccc6)c6ccncc56)cc4)ccc2-3)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 5/20 0.39
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
KDM4E B2RXH2 2/20 0.36
ALDH1A1 P00352 2/20 0.36
MAPT P10636 2/20 0.36
LMNA P02545 1/20 0.36
RECQL P46063 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
FLT3 P36888 1/20 0.36
ACHE P22303 1/20 0.34
DHODH Q02127 3/20 0.34
PGR P06401 1/20 0.34
HPGD P15428 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
TNF P01375 1/20 0.33
ALOX5 P09917 1/20 0.33
PIK3CD O00329 1/20 0.33
DGAT2 Q96PD7 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1104944 0.96 KDM4E (0.38) PDK2MEN1KMT2AKDM4EALDH1A1
SCHEMBL1102678 0.95 PDK2 (0.39) PDK2DHODHTNFALOX5PIK3CD
SCHEMBL1102686 0.94 PDK2 (0.38) PDK2DHODHTNFALOX5PIK3CD
SCHEMBL1104948 0.93 LMNA (0.39) PDK2MEN1KMT2AKDM4EALDH1A1
SCHEMBL1102542 0.93 PDK2 (0.39) PDK2DHODHTNFALOX5PIK3CD
SCHEMBL16298676 0.92 PDK2 (0.41) PDK2MEN1KMT2AKDM4EALDH1A1
SCHEMBL1102799 0.92 PDK2 (0.42) PDK2TNFALOX5PIK3CDDGAT2
SCHEMBL1102673 0.91 PDK2 (0.37) PDK2DHODHTNFALOX5PIK3CD
SCHEMBL16298709 0.91 PDK2 (0.39) PDK2MEN1KMT2AKDM4EALDH1A1
SCHEMBL16298678 0.90 LMNA (0.37) PDK2MEN1KMT2AKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8153279-B2 Organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2012-04-10 US disclosed
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same ORMDL3, OCIAD2, OCIAD1 PDK2 1930/4885MEN1 4462/4885KMT2A 3930/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.